| C797S resistance: the undruggable EGFR mutation in non-small cell lung cancer? T Grabe, J Lategahn, D Rauh ACS medicinal chemistry letters 9 (8), 779-782, 2018 | 49 | 2018 |
| Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797S J Lategahn, M Keul, P Klövekorn, HL Tumbrink, J Niggenaber, MP Müller, ... Chemical Science 10 (46), 10789-10801, 2019 | 33 | 2019 |
| Complex crystal structures of EGFR with third-generation kinase inhibitors and simultaneously bound allosteric ligands J Niggenaber, L Heyden, T Grabe, MP Müller, J Lategahn, D Rauh ACS Medicinal Chemistry Letters 11 (12), 2484-2490, 2020 | 32 | 2020 |
| Synthesis of well-defined core–shell nanoparticles based on bifunctional poly (2-oxazoline) macromonomer surfactants and a microemulsion polymerization process AL Kampmann, T Grabe, C Jaworski, R Weberskirch RSC advances 6 (102), 99752-99763, 2016 | 29 | 2016 |
| Insight into targeting Exon20 insertion mutations of the epidermal growth factor receptor with wild type-sparing inhibitors J Lategahn, HL Tumbrink, C Schultz-Fademrecht, A Heimsoeth, L Werr, ... Journal of medicinal chemistry 65 (9), 6643-6655, 2022 | 14 | 2022 |
| Targeting Her2-insYVMA with Covalent Inhibitors—A Focused Compound Screening and Structure-Based Design Approach J Lategahn, J Hardick, T Grabe, J Niggenaber, K Jeyakumar, M Keul, ... Journal of medicinal chemistry 63 (20), 11725-11755, 2020 | 9 | 2020 |
| Addressing the Osimertinib Resistance Mutation EGFR-L858R/C797S with Reversible Aminopyrimidines T Grabe, K Jeyakumar, J Niggenaber, T Schulz, S Koska, S Kleinbölting, ... ACS Medicinal Chemistry Letters 14 (5), 591-598, 2023 | 2 | 2023 |
| A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2 S Palei, J Weisner, M Vogt, R Gontla, B Buchmuller, C Ehrt, T Grabe, ... RSC Medicinal Chemistry 13 (12), 1540-1548, 2022 | 1 | 2022 |
| Correction: A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2 S Palei, J Weisner, M Vogt, R Gontla, B Buchmuller, C Ehrt, T Grabe, ... RSC Medicinal Chemistry 15 (2), 753-754, 2024 | | 2024 |
| Strukturbasiertes Design, Synthese und Evaluierung von Inhibitoren krebsrelevanter EGFR-Mutationen T Grabe Dissertation, Dortmund, Technische Universität, 2021, 0 | | |
